tradingkey.logo

InterCure Ltd

INCR

1.460USD

-0.030-2.01%
Close 09/19, 16:00ETQuotes delayed by 15 min
66.54MMarket Cap
3.18P/E TTM

InterCure Ltd

1.460

-0.030-2.01%

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated: 2025-09-19

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Despite a good stock market performance, the company shows weak fundamentals and technicals, which don't support the current trend. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
63 / 72
Overall Ranking
508 / 4720
Industry
Healthcare Providers & Services

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 0 analysts
--
Current Rating
--
Target Price
--
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
InterCure Ltd is an Israel-based company primarily enagged in cannabis industry. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.
Overvalued
The company’s latest PE is -1.07, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 16.78M shares, increasing 6.02% quarter-over-quarter.

Financial Health

Currency: USD Updated: 2025-09-19

The company's current financial score is 3.54, which is lower than the Healthcare Providers & Services industry's average of 7.42. Its financial status is stable, and its operating efficiency is low. Its latest quarterly revenue reached 102.44M, representing a year-over-year increase of 7.52%, while its net profit experienced a year-over-year increase of 68.77%.

Score

Industry at a Glance

Previous score
3.54
Change
0

Financials

6.34

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data

Quality of Earnings

0.00

Operational Efficiency

1.37

Growth Potential

4.98

Shareholder Returns

5.00

Company Valuation

Currency: USD Updated: 2025-09-19

The company’s current valuation score is 1.20, which is lower than the Healthcare Providers & Services industry's average of 2.34. Its current P/E ratio is -1.10, which is 4.66% below the recent high of -1.15 and -50.29% above the recent low of -1.65.

Score

Industry at a Glance

Previous score
1.20
Change
0

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 63/72
No Data

Earnings Forecast

Currency: USD Updated: 2025-09-19

There is no earnings forecast score for this company; the Healthcare Providers & Services industry's average is 7.58.

Score

Industry at a Glance

Previous score
0.00
Change
0

Support & Resistance

No Data
No Data

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-09-19

The company’s current price momentum score is 5.69, which is lower than the Healthcare Providers & Services industry's average of 7.21. Sideways: Currently, the stock price is trading between the resistance level at 1.64 and the support level at 1.41, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
5.69
Change
0.09

Support & Resistance

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(3)
Neutral(1)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.034
Sell
RSI(14)
36.775
Neutral
STOCH(KDJ)(9,3,3)
11.441
Oversold
ATR(14)
0.058
Low Volatility
CCI(14)
-159.067
Sell
Williams %R
95.000
Oversold
TRIX(12,20)
-0.155
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
1.517
Sell
MA10
1.551
Sell
MA20
1.587
Sell
MA50
1.565
Sell
MA100
1.551
Sell
MA200
1.543
Sell

Institutional Confidence

Currency: USD Updated: 2025-09-19

Score

Industry at a Glance

Previous score
3.00
Change
0

Institutional Shareholding

No Data

Shareholder Activity

Name
Shares Held
Chg %
Rabinovitch (Alexander)
14.24M
+17.02%
Ibex Investors LLC
1.89M
--
Healthcare Of Ontario Pension Plan
212.50K
--
AdvisorShares Investments, LLC
108.04K
--
Moore Capital Management, LP
Star Investors
97.27K
--
Renaissance Technologies LLC
Star Investors
48.40K
+0.21%
Citadel Advisors LLC
42.32K
+0.40%
Dimensional Fund Advisors, L.P.
34.25K
--
Geode Capital Management, L.L.C.
22.54K
--
BlackRock Financial Management, Inc.
17.23K
--
1
2

Risk Assessment

Currency: USD Updated: 2025-09-19

The company’s current risk assessment score is 4.66, which is higher than the Healthcare Providers & Services industry's average of 4.18. The company's beta value is 1.47. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.

Score

Industry at a Glance

Previous score
4.66
Change
0
Beta vs S&P 500 index
1.46
VaR
+6.22%
240-Day Maximum Drawdown
+37.43%
240-Day Volatility
+64.57%
Return
Best Daily Return
60 days
+12.67%
120 days
+12.67%
5 years
+394.57%
Worst Daily Return
60 days
-5.20%
120 days
-6.01%
5 years
-21.28%
Sharpe Ratio
60 days
-0.16
120 days
+0.44
5 years
+0.41
Risk Assessment
Maximum Drawdown
240 days
+37.43%
3 years
+81.64%
5 years
--
Return-to-Drawdown Ratio
240 days
-0.48
3 years
-0.28
5 years
--
Skewness
240 days
+2.24
3 years
+1.04
5 years
+27.61
Volatility
Realised Volatility
240 days
+64.57%
5 years
--
Standardised True Range
240 days
+4.93%
5 years
--
Downside Risk-Adjusted Return
120 days
+95.97%
240 days
+95.97%
Maximum Daily Upside Volatility
60 days
+45.10%
Maximum Daily Downside Volatility
60 days
+33.39%
Liquidity
Average Turnover Rate
60 days
+0.07%
120 days
+0.05%
5 years
--
Turnover Deviation
20 days
-13.43%
60 days
-27.55%
120 days
-47.31%

Peer Comparison

Healthcare Providers & Services
InterCure Ltd
InterCure Ltd
INCR
2.99 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Labcorp Holdings Inc
Labcorp Holdings Inc
LH
7.74 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Privia Health Group Inc
Privia Health Group Inc
PRVA
7.59 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Progyny Inc
Progyny Inc
PGNY
7.57 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Tenet Healthcare Corp
Tenet Healthcare Corp
THC
7.52 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
US Physical Therapy Inc
US Physical Therapy Inc
USPH
7.43 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI